Personalized, clinician-prescribed peptide protocols , BPC-157, ipamorelin, sermorelin, GHK-Cu, PT-141 and more. For tissue repair, growth hormone optimization, sexual function, skin and hair, and metabolic health.
Each peptide protocol is clinician-prescribed based on your labs, symptoms, and goals. And compounded by a US-licensed pharmacy. Not all peptides are appropriate for everyone.
Speed soft-tissue, tendon and gut repair. Used by athletes and post-surgical patients to shorten downtime and reduce inflammation.
Stimulate your body's own growth hormone release. Lean muscle, deeper sleep, faster recovery. A targeted alternative to direct HGH.
Copper peptide and growth-factor protocols to support collagen, skin elasticity, hair density, and wound healing. Topical and injectable options.
PT-141 (bremelanotide) acts on the central nervous system. Not vasculature. To support arousal and desire in men and women alike.
GLP-1 and GIP receptor agonists. Semaglutide and tirzepatide. For sustainable weight loss, blood sugar control, and appetite regulation.
Neuro-protective and longevity-focused peptides studied for focus, stress resilience, and cellular repair. Limited human data. Clinician guidance essential.
Peptides are powerful signaling molecules. Every protocol on DirectCare AI starts with a medical intake and is built around your goals and (where indicated) bloodwork.
Share your symptoms, goals, and history. 2 to 3 minutes, fully online, HIPAA-encrypted.
Some protocols (GH peptides, GLP-1, longevity stacks) benefit from baseline bloodwork.
A US-licensed clinician picks the right peptide and dose for your goals, or tells you it isn't a fit.
Medication compounded by a US pharmacy, delivered discreetly to your door.
Check-ins and dose adjustments throughout your program. Message your clinician anytime.
Adult men and women looking for targeted, clinician-guided peptide protocols. And who meet the clinical criteria for the specific peptide selected by your provider.
Every peptide protocol is selected by a clinician. Not pulled off a Reddit thread or a gym forum.
Our peptide program is in final clinical review, timed to an expected 2026 shift in FDA compounding guidance. We'll announce availability the moment it's cleared. Check back, or explore everything we already treat.